Nucleotide Purification for Next-Generation Sequencing Accuracy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Next-generation sequencing technologies face challenges with impurities in modified nucleotides, leading to out-of-phase monoclonal amplicons and reduced sequencing accuracy and read lengths due to discrimination by DNA polymerases.

Innovation Solution

A composition and method involving nucleotides with and without a free 3′-OH, along with reagents like depletion primers, templates, and nucleotide cyclases, are used to decrease the amount of 3′-OH nucleotides, ensuring accurate sequencing by maintaining nucleotide synchrony and stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If modified nucleotides with reversible terminators are used in NGS, then sequencing capability is enabled, but impurities (natural nucleotides and non-reversible terminator-containing nucleotides) reduce sequencing accuracy and read lengths

Engineering Contradiction:
Improvesequencing accuracyVSAvoidnucleotide impurities
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent extracts and removes harmful impurities (natural nucleotides and non-reversible terminator-containing nucleotides) from the modified nucleotide mixture through purification steps, depletion primers, and selective enzymatic reactions, thereby improving sequencing accuracy without sacrificing the beneficial sequencing capability

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent changes the chemical parameters of nucleotides by introducing reversible terminators with specific chemical groups that can be controlled to remain blocked or be cleaved, allowing precise control over nucleotide incorporation and enabling accurate sequencing while maintaining nucleotide functionality

Inventive Principle:
Principle #35Parameter changes

2Productivity

If DNA polymerase is used for sequencing, then nucleotide incorporation occurs, but the polymerase discriminates against modified nucleotides in favor of 3′-OH bearing nucleotides, causing out-of-phase amplicons

Engineering Contradiction:
Improvenucleotide incorporation rateVSAvoidnucleotide synchrony
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The patent modifies the chemical parameters of nucleotides by adding reversible terminators with blocked 3′-OH groups, which prevents premature extension and maintains synchrony among amplicons while still allowing controlled incorporation by DNA polymerase when the block is removed

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces reversible terminator nucleotides as intermediary molecules that mediate between the need for controlled nucleotide incorporation and the requirement for synchrony, allowing the polymerase to incorporate nucleotides only when the reversible block is present and controlled

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of operation

If nucleotides with free 3′-OH are present in the sequencing solution, then natural nucleotide incorporation occurs, but this creates out-of-phase clusters and reduces sequencing read lengths

Engineering Contradiction:
Improvenucleotide availabilityVSAvoidsequencing read length
Core Design Contradiction:
Ease of operationVSLength of stationary object

Solution Approach 1:

The patent extracts and removes nucleotides with free 3′-OH groups from the sequencing solution through purification methods and selective depletion reactions, preventing unwanted natural nucleotide incorporation that would cause out-of-phase clusters and limit read lengths

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent applies different quality controls to different nucleotide types by using selective depletion primers and enzymes that specifically target and remove free 3′-OH nucleotides while preserving the modified nucleotides with reversible terminators, ensuring only the desired nucleotides remain available for sequencing

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances sequencing accuracy and read lengths by synchronizing nucleotide incorporation, reducing impurities, and improving storage stability of modified nucleotides.

Implementation Method 1

a depletion polymerase that is active to extend the depletion primer along the depletion template by selectively incorporating the nucleotides including a free 3′-OH

Methodology Applied
Scientific EffectPolymerase incorporation: Enzyme

Implementation Method 2

a nucleotide cyclase, wherein the nucleotide cyclase cyclizes the 3′-OH nucleotide thereby producing a cyclized nucleotide

Methodology Applied
Scientific EffectCyclization: Chemical Bonding

Implementation Method 3

extending the sequencing primer along the target polynucleotide using the sequencing polymerase by incorporating one of the nucleotides lacking a free 3′-OH

Methodology Applied
Scientific EffectPolymerase incorporation: Enzyme

Data Source

PatentUS20240401131A1Methods and compositions for reducing nucleotide impurities
Publication Date: 2024.12.05 SINGULAR GENOMICS SYSTEMS INC
  • US20240401131A1 patent drawing
  • US20240401131A1 patent drawing
  • US20240401131A1 patent drawing

AI summary

Disclosed herein, inter alia, are compositions and methods for depleting nucleotide impurities in nucleotide solutions.